Vigne, J.-L., Murai, J.T., Arbogast, B.W., Jia, W., Fisher, S.J. and Taylor, R.N.: Elevated nonesterified fatty acid concentrations in severe preeclampsia shift the isoelectric characteristics of plasma albumin. J. Clin. Endocrinology and Metabolism 82: 3786-3792, 1997.

Arbogast, B.W. and Taylor, R.N.: Molecular mechanisms of preeclampsia. Springer, New York, 1996.

Arbogast, B.W., Neumann, J.K., Kostrzewa, R.M., Arbogast, L.Y. and Leeper, S.C.: Transient Loss of Serum Protective Activity Following Short Term Stress: A Possible Biochemical Link between Stress and Atherosclerosis. J. Psychosomatic Res. 38: 871-884, 1994.

Arbogast, B.W., Leeper, S.C., Merrick, R.D., Olive, K.E. and Taylor, R.N.: Which plasma factors bring about disturbance of endothelial function in pre-eclampsia? Lancet 343: 340-341, 1994.

Arbogast, B.W.: Purification and Identification of Very Low Density Lipoprotein Toxicity Preventing Activity. Atherosclerosis 73: 259-267, 1988.

Arbogast, B.W. and Dreher, N.J.: Coronary Disease Prediction Using a New Atherogenic Index. Atherosclerosis 66: 55-62, 1987.

Arbogast, B.W., Gill, L.R. and Schwertner, H.A.: A New Protective Factor in Coronary Artery Disease: Very-Low-Density Lipoprotein Toxicity-Preventing Activity. Atherosclerosis 57: 75-86, 1985.

Arbogast, B.W., Berry, D.L. and Newell, C.L.: Injury of Arterial Endothelial Cells in Diabetic, Sucrose-Fed and Aged Rats. Atherosclerosis 51: 31-45, 1984.

Chi, D.S., Berry, D.L., Dillon, K.A. and Arbogast, B.W.: Inhibition of in Vitro Lymphocyte Response by Streptozotocin-Induced Diabetic Rat Serum: A Function of Very Low Density Lipoproteins. Diabetes 31: 1098-1104, 1982.

Arbogast, B.W., Lee, G.M. and Raymond, T.R.: In Vitro Injury of Porcine Aortic Endothelial Cells by Very Low Density Lipoproteins from Diabetic and Normal Rat Serum. Diabetes 31: 593-599, 1982.